HTRA3 Is a Prognostic Biomarker and Associated With Immune Infiltrates in Gastric Cancer.

Ji, Ce; Sun, Li-Sha; Xing, Fei; Niu, Nan; Gao, Hong-Li; Dai, Jing-Wei; Zhou, Nan; Jiang, Ben-Chun

Ji, Ce; Sun, Li-Sha; Xing, Fei; Niu, Nan; Gao, Hong-Li; Dai, Jing-Wei; Zhou, Nan; Jiang, Ben-Chun.

Afiliação

Ji C; Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, China.
Sun LS; Tumor Stem Cell and Transforming Medicine Laboratory, Shengjing Hospital of China Medical University, Benxi, China.
Xing F; Tumor Stem Cell and Transforming Medicine Laboratory, Shengjing Hospital of China Medical University, Benxi, China.
Niu N; Department of Breast Surgery, Shengjing Hospital of China Medical University, Shenyang, China.
Gao HL; Tumor Stem Cell and Transforming Medicine Laboratory, Shengjing Hospital of China Medical University, Benxi, China.
Dai JW; Department of Breast Surgery, Shengjing Hospital of China Medical University, Shenyang, China.
Zhou N; Tumor Stem Cell and Transforming Medicine Laboratory, Shengjing Hospital of China Medical University, Benxi, China.
Jiang BC; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.

Front Oncol ; 10: 603480, 2020.

Article em En | MEDLINE | ID: mdl-33425760

Palavras-chave

HTRA3; bioinformatics; biomarker; gastric cancer; immune infiltration; prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google